Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 5-oxo-d-prolinepiperidinamide Monohydrate
2. Ns 105
3. Ns-105
1. 110958-19-5
2. Fasoracetam [inn]
3. N-(5-oxo-d-prolyl)piperidine
4. Ns 105 (pharmaceutical)
5. (5r)-5-(piperidine-1-carbonyl)pyrrolidin-2-one
6. Ns-105
7. (r)-5-(piperidine-1-carbonyl)pyrrolidin-2-one
8. (r)-1-((5-oxo-2-pyrrolidinyl)carbonyl)piperidine
9. Lam-105
10. Nfc1 Anhydrous
11. Nfc-1 Anhydrous
12. Lam105 Anhydrous
13. Lam-105 Anhydrous
14. 42o8uf5cjb
15. Ncgc00182992-01
16. Aevi001
17. Aevi-001
18. Chebi:31592
19. Ns105
20. (+)-1-(((r)-5-oxo-2-pyrrolidinyl)carbonyl)piperidine
21. (5r)-5-(1-piperidinylcarbonyl)-2-pyrrolidinone
22. (r)-1-[(5-oxo-2-pyrrolidinyl)carbonyl]piperidine
23. 2-pyrrolidinone, 5-(1-piperidinylcarbonyl)-, (5r)-
24. Unii-42o8uf5cjb
25. Piperidine, 1-((5-oxo-2-pyrrolidinyl)carbonyl)-, (r)-
26. Dsstox_cid_28781
27. Dsstox_rid_83050
28. Dsstox_gsid_48855
29. Schembl194770
30. Chembl2106179
31. Dtxsid9048855
32. Ex-a736
33. Bcp16788
34. Zinc3779713
35. Tox21_113340
36. Mfcd00875708
37. Ns 105
38. Akos006280726
39. 4-methyl-6-trifluoromethylnicotinicacid
40. Ac-31949
41. Bs-49484
42. Fasoracetam ;aka Ns-105 ;lam-105)
43. Cas-110958-19-5
44. (5r)-5-(piperidine-1-carbonyl) Pyrrolidin-2-one
45. A894820
46. Q5436839
Molecular Weight | 196.25 g/mol |
---|---|
Molecular Formula | C10H16N2O2 |
XLogP3 | 0 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 1 |
Exact Mass | 196.121177757 g/mol |
Monoisotopic Mass | 196.121177757 g/mol |
Topological Polar Surface Area | 49.4 Ų |
Heavy Atom Count | 14 |
Formal Charge | 0 |
Complexity | 247 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Fasoracetam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fasoracetam, including repackagers and relabelers. The FDA regulates Fasoracetam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fasoracetam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Fasoracetam supplier is an individual or a company that provides Fasoracetam active pharmaceutical ingredient (API) or Fasoracetam finished formulations upon request. The Fasoracetam suppliers may include Fasoracetam API manufacturers, exporters, distributors and traders.
click here to find a list of Fasoracetam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fasoracetam DMF (Drug Master File) is a document detailing the whole manufacturing process of Fasoracetam active pharmaceutical ingredient (API) in detail. Different forms of Fasoracetam DMFs exist exist since differing nations have different regulations, such as Fasoracetam USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Fasoracetam DMF submitted to regulatory agencies in the US is known as a USDMF. Fasoracetam USDMF includes data on Fasoracetam's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fasoracetam USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Fasoracetam suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fasoracetam as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fasoracetam API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fasoracetam as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fasoracetam and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fasoracetam NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fasoracetam suppliers with NDC on PharmaCompass.
Fasoracetam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fasoracetam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fasoracetam GMP manufacturer or Fasoracetam GMP API supplier for your needs.
A Fasoracetam CoA (Certificate of Analysis) is a formal document that attests to Fasoracetam's compliance with Fasoracetam specifications and serves as a tool for batch-level quality control.
Fasoracetam CoA mostly includes findings from lab analyses of a specific batch. For each Fasoracetam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fasoracetam may be tested according to a variety of international standards, such as European Pharmacopoeia (Fasoracetam EP), Fasoracetam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fasoracetam USP).
LOOKING FOR A SUPPLIER?